| Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine FP Polack, SJ Thomas, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... New England journal of medicine 383 (27), 2603-2615, 2020 | 14500 | 2020 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review … T Shi, DA McAllister, KL O'Brien, EAF Simoes, SA Madhi, BD Gessner, ... The Lancet 390 (10098), 946-958, 2017 | 2103 | 2017 |
| Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months SJ Thomas, ED Moreira Jr, N Kitchin, J Absalon, A Gurtman, S Lockhart, ... New England Journal of Medicine 385 (19), 1761-1773, 2021 | 1333 | 2021 |
| Early high-titer plasma therapy to prevent severe Covid-19 in older adults R Libster, G Pérez Marc, D Wappner, S Coviello, A Bianchi, V Braem, ... New England Journal of Medicine 384 (7), 610-618, 2021 | 948 | 2021 |
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 726 | 2014 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a … Y Li, X Wang, DM Blau, MT Caballero, DR Feikin, CJ Gill, SA Madhi, ... The Lancet 399 (10340), 2047-2064, 2022 | 591 | 2022 |
| Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease MF Delgado, S Coviello, AC Monsalvo, GA Melendi, JZ Hernandez, ... Nature medicine 15 (1), 34-41, 2009 | 577 | 2009 |
| Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina R Libster, J Bugna, S Coviello, DR Hijano, M Dunaiewsky, N Reynoso, ... New England Journal of Medicine 362 (1), 45-55, 2010 | 531 | 2010 |
| A role for immune complexes in enhanced respiratory syncytial virus disease FP Polack, MN Teng, P L. Collins, GA Prince, M Exner, H Regele, ... The Journal of experimental medicine 196 (6), 859-865, 2002 | 457 | 2002 |
| The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ... The Lancet Infectious Diseases 18 (10), e295-e311, 2018 | 415 | 2018 |
| Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants RA Karron, PF Wright, RB Belshe, B Thumar, R Casey, F Newman, ... The Journal of infectious diseases 191 (7), 1093-1104, 2005 | 361 | 2005 |
| Respiratory syncytial virus hospitalization and mortality: systematic review and meta‐analysis RT Stein, LJ Bont, H Zar, FP Polack, C Park, A Claxton, G Borok, ... Pediatric pulmonology 52 (4), 556-569, 2017 | 320 | 2017 |
| Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study X Wang, Y Li, KL O'brien, SA Madhi, MA Widdowson, P Byass, SB Omer, ... The Lancet Global Health 8 (4), e497-e510, 2020 | 309 | 2020 |
| Respiratory syncytial virus vaccination during pregnancy and effects in infants SA Madhi, FP Polack, PA Piedra, FM Munoz, AA Trenholme, EAF Simões, ... New England Journal of Medicine 383 (5), 426-439, 2020 | 306 | 2020 |
| Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes AC Monsalvo, JP Batalle, MF Lopez, JC Krause, J Klemenc, ... Nature medicine 17 (2), 195-199, 2011 | 292 | 2011 |
| Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics NI Mazur, F Martinón-Torres, E Baraldi, B Fauroux, A Greenough, ... The Lancet Respiratory Medicine 3 (11), 888-900, 2015 | 282 | 2015 |
| Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response KH Antunes, JL Fachi, R de Paula, EF da Silva, LP Pral, AÁ Dos Santos, ... Nature communications 10 (1), 3273, 2019 | 275 | 2019 |
| Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants B Kampmann, SA Madhi, I Munjal, EAF Simões, BA Pahud, C Llapur, ... New England Journal of Medicine 388 (16), 1451-1464, 2023 | 270 | 2023 |
| Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series NM Scheltema, A Gentile, F Lucion, DJ Nokes, PK Munywoki, SA Madhi, ... The Lancet Global Health 5 (10), e984-e991, 2017 | 255 | 2017 |
| Brief history and characterization of enhanced respiratory syncytial virus disease PL Acosta, MT Caballero, FP Polack Clinical and Vaccine Immunology 23 (3), 189-195, 2016 | 242 | 2016 |
